Maher Albitar
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 21
- Acute Myeloid Leukemia Research 19
- Hematopoietic Stem Cell Transplantation 4
- Co-authors
- Francis J. Giles (1 shared paper)Petr Starostik (2 shared papers)Michael Keating (2 shared papers)John C. Reed (1 shared paper)C M Croce (1 shared paper)Debora Rasio (1 shared paper)Shinichi Kitada (1 shared paper)Florencia Bullrich (1 shared paper)
- Journals
- Blood (18 papers)Journal of Clinical Oncology (7 papers)Cancer (2 papers)Cancers (2 papers)Journal of Immunotherapy (1 paper)
- Partner nations
- United StatesSaudi ArabiaPakistan
In The Last Decade
Maher Albitar
46 papers receiving 761 citations
Peers
Comparison fields: 5 of 62
- Hematology 305
- Genetics 287
- Pathology and Forensic Medicine 197
- Oncology 213
- Cancer Research 110
Countries citing papers authored by Maher Albitar
This map shows the geographic impact of Maher Albitar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maher Albitar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maher Albitar more than expected).
Fields of papers citing papers by Maher Albitar
This network shows the impact of papers produced by Maher Albitar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maher Albitar. The network helps show where Maher Albitar may publish in the future.
Co-authors
The 25 scholars most cited alongside Maher Albitar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ATM mutations in B-cell chronic lymphocytic leukemia. | 1999 | 189 |
| 2 | 2000 | 99 | |
| 3 | 1995 | 60 | |
| 4 | 2005 | 50 | |
| 5 | Autocrine interleukin-1beta production in leukemia: evidence for the involvement of mutated RAS. | 1999 | 48 |
| 6 | 2002 | 41 | |
| 7 | Combined fludarabine, cyclophosphamide, and rituximab achieves a high complete remission rate as initial treatment for chronic lymphocytic leukemia | 2001 | 39 |
| 8 | 2020 | 33 | |
| 9 | 2005 | 27 | |
| 10 | 2003 | 23 | |
| 11 | 2005 | 15 | |
| 12 | 2023 | 14 | |
| 13 | 2006 | 14 | |
| 14 | 2005 | 13 | |
| 15 | 1997 | 12 | |
| 16 | 2022 | 12 | |
| 17 | 2005 | 9 | |
| 18 | 2000 | 9 | |
| 19 | 2024 | 7 | |
| 20 | 1995 | 6 |
About Maher Albitar
Maher Albitar is a scholar working on Hematology, Molecular Biology, Cancer Research, Genetics and Pathology and Forensic Medicine, having authored 48 papers that have together received 783 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (19 papers), Cancer Genomics and Diagnostics (13 papers), Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (9 papers), Acute Lymphoblastic Leukemia research (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). The work is most often cited by research in Hematology (305 citations), Genetics (287 citations), Pathology and Forensic Medicine (197 citations), Oncology (213 citations) and Cancer Research (110 citations). Maher Albitar has collaborated with scholars based in United States, Saudi Arabia and Pakistan. Frequent co-authors include Francis J. Giles, Petr Starostik, Michael Keating, John C. Reed, C M Croce, Debora Rasio, Shinichi Kitada, Florencia Bullrich, Francis J. Giles and Zeev Estrov. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer, Cancers and Journal of Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.